HIV & AIDS

New York City promotes acceptance of controversial HIV drug

New York City's health department is advertising on gay hookup apps and lobbying doctors to promote wider use of a controversial anti-HIV pill that vastly cuts the risk of infection. But the therapy has stoked infighting ...

HIV & AIDS

Usage remains low for pill that can prevent HIV infection

From gritty neighborhoods in New York and Los Angeles to clinics in Kenya and Brazil, health workers are trying to popularize a pill that has proven highly effective in preventing HIV but which—in their view—remains woefully ...

HIV & AIDS

US health advisors mull AIDS prevention pill (Update)

US health advisers on Thursday urged regulators to approve Truvada, made by Gilead Sciences, as the first preventive pill against HIV/AIDS instead of just a treatment for infected people.

HIV & AIDS

Sex, drugs, stigma put Thai transsexuals at HIV risk

From a cafe near the go-go bars of a Bangkok red light district where she campaigns for safe sex, Gigi gives an unvarnished view of how she joined Thailand's growing ranks of transgender people with HIV.

HIV & AIDS

NIH-funded analysis estimates effective PrEP dosing

Several large clinical trials have demonstrated that a daily oral dose of one or two antiretroviral drugs used to treat HIV infection can prevent infection in an approach known as pre-exposure prophylaxis, or PrEP. The level ...

page 3 from 4